HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Treatment for advanced NSCLC no longer a one-size-fits-all approach
• ACIP recommends routine HPV vaccination for 11- to 12-year-old boys
• Annual congress highlights benefits of tailoring treatment to disease risk factors, patients’ status Edward Gordon-Smith, MD
• Colleague, patient feedback on professionalism should be taken with caution
• DFMO had protective effect against nonmelanoma skin cancers
• Diabetes-cancer link raises flags Derek LeRoith, MD, PhD
• Drinking plenty of fluids may decrease bladder cancer risk in men
• EPIC: Smoking surpasses hepatitis B in raising risk for hepatocellular carcinoma
• FDA approves premarket application for melanoma device
• Participation gap in cancer screening between men and women
• Radioiodine ablation, TSH stimulation warranted in low-risk patients
• Reduction in surgery, evolution of systemic therapies highlight recent treatment
• A 51-year-old male, non-smoker with hemoptysis and lung nodules Ramya Varadarajan, MD
• Patient with latent prostate cancer reports history of decreased night vision Thomas R. Hedges III, MD; Jordana F. Goren, MD, MS
• Diabetes–cancer link raises flags for endocrinologists Derek LeRoith, MD, PhD
• Interruption of dabigatran therapy at times of surgery, colonoscopy and other procedures Stephan Moll, MD; Beth Walden, MA
• Transplant recipients at increased risk for various cancer types
• The quest for empathy in academic oncology William Wood, MD
• Age no longer a barrier to hematopoietic stem cell transplantation
• Although safe, certain oral contraceptives confer increased risk for VTE
• Biomarker may detect GVHD of the gastrointestinal tract after HSCT
• Bisphosphonate use decreased contralateral breast cancer risk among ER-positive cases
• Even low alcohol intake increased risk for breast cancer
• Folate intake not linked to pancreatic cancer risk
• Mammography appears unlikely to save a woman's life
• No increased risk for second cancer after brachytherapy
• Non-carriers of familial BRCA mutations at no increased risk for breast cancer
• PLCO: Annual chest radiographic screening failed to reduce lung cancer mortality
• Unjustified use of hormone therapy high among elderly women with breast cancer
• CPS-II: Adult weight gain associated with increased risk for endometrial cancer
• Glitazone pretreatment boosted I-131 uptake
• Management of medullary thyroid cancer remains challenging
• NSAIDs associated with reduced colorectal cancer mortality